Skip to main content
Log in

Assessing attitudes and behaviours surrounding Alzheimer’s disease in Europe: Key findings of the important perspectives on Alzheimer’s care and treatment (IMPACT) survey

  • JNHA: Clinical Neurosciences
  • Published:
The journal of nutrition, health & aging

Abstract

The Important Perspectives on Alzheimer’s Care and Treatment (IMPACT) survey is an assessment in Europe of the attitudes of caregivers, physicians, the general public and payors towards Alzheimer’s disease and dementia. This was an Internet-based questionnaire study, which sought to determine the opinion and perception of responders on issues relating to ageing and dementia. There were additional questions for caregivers on the impact of caregiving on their life. Responses were analysed from 949 members of the general public, 500 physicians (generalists and specialists), 250 caregivers and 50 payors from 5 countries—France, Germany, Italy, Spain and the United Kingdom. The survey highlighted the difficulty of diagnosing dementia, especially in the initial stages of the disease. The average time from first noticing symptoms to diagnosis varied from 36 to 63 weeks. Caregivers and the general public felt they had insufficient information about the benefits of treatment and care, although more than half the general public, caregiver and physician responders agreed that early treatment could delay the progression of the disease. The majority of respondents recognised the devastating effects of AD on caregivers and families, and a majority of caregivers, the general public and physicians agreed that their governments fail to view AD as a health care priority. This study occurs roughly 5 years after a similar survey, and provides a timely update. Despite some important differences between the methodologies used in these surveys, diagnosis of dementia is still a key issue, especially amongst generalists, as is the provision of information and support to caregivers. Despite the prevalence of AD in the ageing population of Europe, the perception within each of the 5 countries surveyed is that AD is not viewed as a health care priority.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66(10):1210–1215.

    Article  PubMed  Google Scholar 

  2. Hofman A, Rocca W, Brayne C, et al. The prevalence of dementia in Europe: a collaborative study of 1980–1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol. 1991;20(3):736–748.

    Article  CAS  PubMed  Google Scholar 

  3. Pedro-Cuesta J, Virues-Ortega J, Vega S, et al. Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990–2008. BMC Neurol. 2009;9:55.

    Article  PubMed  Google Scholar 

  4. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111–128.

    PubMed  Google Scholar 

  5. Warner J, Butler R. Alzheimer’s disease. Clin Evid. 2000;3:419–425.

    Google Scholar 

  6. Mura T, Dartigues J-F, Berr C. How many dementia cases in France and Europe? Alternative projections and scenarios 2010–2050. Eur J Neurol. 2010;17(2):252–259.

    Article  CAS  PubMed  Google Scholar 

  7. European Commission Web site. Alzheimer disease and other dementias. Available at: http://ec.europa.eu/health/ph_information/dissemination/diseases/alzheimer_en.htm. Accessed February 11, 2010.

  8. Musicco M. Gender differences in the occurrence of Alzheimer’s disease. Funct Neurol. 2009;24(2):89–92.

    PubMed  Google Scholar 

  9. Kovacs GG, Alafuzoff I, Al Sarraj S, et al. Mixed brain pathologies in dementia: the BrainNet Europe consortium experience. Dement Geriatr Cogn Disord. 2008;26(4):343–350.

    Article  PubMed  Google Scholar 

  10. Boise L, Camicioli R, Morgan DL, Rose JH, Congleton L. Diagnosing dementia: perspectives of primary care physicians. Gerontologist. 1999;39(4):457–464.

    CAS  PubMed  Google Scholar 

  11. Urbanelli L, Magini A, Ciccarone V, et al. New perspectives for the diagnosis of Alzheimer’s disease. Recent Pat CNS Drug Discov. 2009;4(3):160–181.

    Article  CAS  PubMed  Google Scholar 

  12. Weimer DL, Sager MA. Early identification and treatment of Alzheimer’s disease: social and fiscal outcomes. Alzheimers Dement. 2009;5(3):215–226.

    Article  PubMed  Google Scholar 

  13. Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer’s Association, and the American Geriatrics Society. JAMA. 1997;278(16):1363–1371.

    Article  CAS  PubMed  Google Scholar 

  14. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer’s disease. Am J Psychiatry. 2005;162(11):2086–2093.

    Article  PubMed  Google Scholar 

  15. Kurz A, Schulz M, Reed P, et al. Personal perspectives of persons with Alzheimer’s disease and their carers: a global survey. Alzheimers Dement. 2008;4(5):345–352.

    Article  PubMed  Google Scholar 

  16. Schoenmakers B, Buntinx F, DeLepeleire J. Supporting the dementia family caregiver: the effect of home care intervention on general well-being. Aging Ment Health. 2010;14(1):44–56.

    Article  PubMed  Google Scholar 

  17. Hamilton L. Dementia: early diagnosis is vital for best care. Nurs Times. 2001;97(9):41–42.

    CAS  PubMed  Google Scholar 

  18. Berr C, Wancata J, Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol. 2005;15(4):463–371.

    Article  CAS  PubMed  Google Scholar 

  19. Jonsson L, Wimo A. The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics. 2009;27(5):391–403.

    Article  PubMed  Google Scholar 

  20. Quentin W, Riedel-Heller SG, Luppa M, Rudolph A, König HH. Cost-of-illness studies of dementia: a systematic review focusing on stage dependency costs. Acta Psychiatr Scand. 2009 Aug 19. [Epub ahead of print].

  21. Jedenius E, Wimo A, Strömqvist J, Jönsson L, Andreasen N. The cost of diagnosing dementia in a community setting. Int J Geriatr Psychiatry. 2010;25(5):476–482.

    Article  PubMed  Google Scholar 

  22. Bazin N, Fremont P. [Alzheimer type dementia: is early diagnosis significant?] Presse Med. 2000;29(15):871–875. [Article in French].

    CAS  PubMed  Google Scholar 

  23. Eaton L. Government strategy on dementia will emphasise early diagnosis. BMJ. 2009;338:b367.

    Article  PubMed  Google Scholar 

  24. Maeck L, Haak S, Knoblauch A, Stoppe G. Early diagnosis of dementia in primary care: a representative eight-year follow-up study in Lower Saxony, Germany. Int J Geriatr Psychiatry. 2007;22(1):23–31.

    Article  PubMed  Google Scholar 

  25. Alzheimer Europe Web site. European action on dementia. Available at: http://www.alzheimer-europe.org/Policy-in-Practice/European-Action-on-Dementia/. Accessed February 11, 2010.

  26. Duara R, Barker W, Loewenstein D, Bain L. The basis for disease-modifying treatments for Alzheimer’s disease: the Sixth Annual Mild Cognitive Impairment Symposium. Alzheimers Dement. 2009;5(1):66–74.

    Article  PubMed  Google Scholar 

  27. Keightley J, Mitchell A. What factors influence mental health professionals when deciding whether or not to share a diagnosis of dementia with the person? Aging Ment Health. 2004;8(1):13–20.

    Article  CAS  PubMed  Google Scholar 

  28. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006 (1):CD005593.

  29. Tschape JA, Hartmann T. Therapeutic perspectives in Alzheimer’s disease. Recent Pat CNS Drug Discov. 2006;1(1):119–127.

    Article  PubMed  Google Scholar 

  30. Draper B, Peisah C, Snowdon J, Brodaty H. Early dementia diagnosis and the risk of suicide and euthanasia. Alzheimers Dement. 2010;6(1):75–82.

    Article  PubMed  Google Scholar 

  31. Edvardsson D, Winblad B, Sandman PO. Person-centred care of people with severe Alzheimer’s disease: current status and ways forward. Lancet Neurol. 2008;7(4):362–367.

    Article  PubMed  Google Scholar 

  32. Georges J, Jansen S, Jackson J, Meyrieux A, Sadowska A, Selmes M. Alzheimer’s disease in real life—the dementia carer’s survey. Int J Geriatr Psychiatry. 2008;23(5):546–551.

    Article  PubMed  Google Scholar 

  33. Department of Health. Living well with dementia: A national dementia strategy. Available at: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_094051.pdf. Accessed March 4, 2010.

  34. Wilkinson D. Is there a double standard when it comes to dementia care? Int J Clin Pract Suppl. 2005 (146):3–7.

  35. Galvin JE, Meuser TM, Boise L, Connell CM. Predictors of physician referral for patient recruitment to Alzheimer disease clinical trials. Alzheimer Dis Assoc Disord. 2009;23(4):352–356.

    Article  PubMed  Google Scholar 

  36. Geldmacher DS. Cost-effective recognition and diagnosis of dementia. Semin Neurol. 2002;22(1):63–70.

    Article  PubMed  Google Scholar 

  37. Patterson CJ, Gauthier S, Bergman H, et al. The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ. 1999;160(12 Suppl):S1–S15.

    CAS  PubMed  Google Scholar 

  38. Cutler SJ, Hodgson LG. Anticipatory dementia: a link between memory appraisals and concerns about developing Alzheimer’s disease. Gerontologist. 1996;36(5):657–664.

    CAS  PubMed  Google Scholar 

  39. Laforce R, Jr., McLean S. Knowledge and fear of developing Alzheimer’s disease in a sample of healthy adults. Psychol Rep. 2005;96(1):204–206.

    Article  PubMed  Google Scholar 

  40. Wilkinson D, Sganga A, Stave C, O’Connell B. Implications of the Facing Dementia Survey for health care professionals across Europe. Int J Clin Pract Suppl. 2005 (146):27–31.

  41. Bond J, Stave C, Sganga A, O’Connell B, Stanley RL. Inequalities in dementia care across Europe: key findings of the Facing Dementia Survey. Int J Clin Pract Suppl. 2005 (146):8–14.

  42. Reynish E, Cortes F, Andrieu S, et al. The ICTUS study: a prospective longitudinal observational study of 1,380 AD patients in Europe. Study design and baseline characteristics of the cohort. Neuroepidemiology. 2007;29(1–2):29–38.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roy W. Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, R.W., Mackell, J., Berthet, K. et al. Assessing attitudes and behaviours surrounding Alzheimer’s disease in Europe: Key findings of the important perspectives on Alzheimer’s care and treatment (IMPACT) survey. J Nutr Health Aging 14, 525–530 (2010). https://doi.org/10.1007/s12603-010-0263-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12603-010-0263-y

Key words

Navigation